Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:

Greenberg Traurig LLP counsels innovative life sciences companies in the biotech, pharma, medical devices, and healthcare sectors. It handles regulatory and transactional matters, while being particularly strong in IP. The team advises on IP portfolio management and diligence, litigation, and sale internationally, with ‘excellent knowledge’ across jurisdictions. The practice is co-headed by Boston-based patent attorney David Dykeman, focused on securing worldwide IP protection, and Atlanta’s Wayne Elowe, who concentrates on worldwide corporate counseling and complex commercial transactions, such as M&A and joint ventures. Melissa Hunter-Ensor, in Boston, experienced in IP portfolio management, strategic alliances, and litigation strategy, is a key figure in the practice. Chia-Feng Lu, based in Washington DC and Tokyo, applies his ’strategic thinking’ to regulatory and transactional law.
Legal 500 redaktioneller Kommentar

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • ‘The team's people, attention to detail, knowledge of the technology and business sense is what sets them apart from other firms in the life sciences practice. The team has consistently exceeded expectations with their knowledge and responsiveness.’

  • ‘GT has the unique ability to understand a client's technology, understand the client's strategy to create significant value and provide specific and high quality legal services to support this strategy. GT has strength across the various aspects of Life Sciences legal services, including patent/IP protection, regulatory, reimbursement, digital, etc., and experience in pharma, devices, and digital, which makes it quite powerful and great to work with. The quality of its lawyers in each area is outstanding.’

Kernmandanten

  • Provention Bio, Inc.
  • Micron Biomedical – Bill & Melinda Gates Foundation Grant